PhRMA

PhRMA Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from PhRMA, Medical and health, 670 Maine Avenue SW Ste. 1000, Washington D.C., DC.

We represent America’s innovative biopharmaceutical research & biotechnology companies, advocating for policies that support the discovery of new medicines and ensure broad patient access to safe, effective treatments.

Three years into implementation of the IRA, the evidence is clear: government price-setting is chilling medical innovati...
12/18/2025

Three years into implementation of the IRA, the evidence is clear: government price-setting is chilling medical innovation, halting clinical trials and undermining patient access to innovative treatments.

Take a look at the facts.

12/15/2025

A new PILMA study highlights how America’s biopharmaceutical investment creates opportunity far beyond new medicines.

By building and maintaining manufacturing facilities and R&D labs, our industry provides a vital on-ramp to economic security for union construction workers in the building trades and their families.

And this has a ripple effect, because these jobs fuel local economies and strengthen communities throughout the area.

https://www.innovation.org/casestudy/american-infrastructure-investment/

Too many Americans struggle to afford their medicines because of an insurance system that pushes patients into higher ou...
12/10/2025

Too many Americans struggle to afford their medicines because of an insurance system that pushes patients into higher out-of-pocket costs, denials and delays.

While insurers and PBMs have excluded more medicines from their formularies each year, biopharmaceutical companies are stepping in with direct purchase options and patient support programs that help millions of Americans access the treatments they need.

Launching in January 2026, AmericasMedicines.com will provide a site to find direct purchase and patient support programs. But for now, check out PhRMA’s Medicine Assistance Tool to find patient support available to you.

Washington is searching for ways to lower drug costs, but price setting is not the answer. Three years under the IRA’s p...
12/06/2025

Washington is searching for ways to lower drug costs, but price setting is not the answer. Three years under the IRA’s price setting policies and patients are experiencing higher out-of-pocket costs, more coverage denials and fewer plan choices. That’s because the law does nothing to rein in insurers and PBMs that decide what medicines patients can get and how much they pay.

If policymakers want real affordability, the answer is clear: rein in the middlemen driving up costs, don’t expand a policy that’s failing patients.

12/04/2025

Hepatitis B is serious — but preventable with early protection.

Chief Medical Officer Dr. Mike Ybarra breaks down why the hepatitis B vaccine shortly after birth is one of the most effective ways to protect newborns from lifelong liver disease.

Learn more from Dr. Ybarra.

https://phrma.org/blog/why-the-hepatitis-b-vaccine-matters

12/04/2025

The recommended vaccine schedule isn’t arbitrary—it reflects years of research on when kids are most vulnerable to serious illness. Combination vaccines help families stay on track with fewer appointments and fewer needles. Learn more about the evidence behind vaccine schedules from CMO Dr. Mike Ybarra.

12/04/2025

The recommended vaccine schedule isn’t arbitrary—it reflects years of research on when kids are most vulnerable to serious illness. Combination vaccines help families stay on track with fewer appointments and fewer needles. Learn more about the evidence behind vaccine schedules from CMO Dr. Mike Ybarra.

phrma.org/vaccines

12/03/2025

As part of Merck’s $70B commitment to strengthen U.S. manufacturing and R&D, the company has begun construction on a new state-of-the-art facility at its long-standing Elkton, Virginia site.

This expansion builds on Merck’s nearly 85 years of innovation in the region and is expected to create more than 500 full-time jobs and 8,000 construction roles.

https://innovation.org/casestudy/merck-expands-manufacturing-presence/

12/01/2025

More than 40 years ago, HIV arrived with more questions than answers.

No roadmap. No treatments. No time to waste.

Biopharmaceutical scientists didn’t wait for certainty — they built it.
- They invented ARTs that slashed HIV mortality by ~75%.
- They delivered PrEP, helping reduce new HIV infections.
- And now they’re creating long-acting therapies that may protect people for months at a time.

This is research at its most human: relentless work that gives people decades they thought they’d never have.

▶️ Watch the breakthroughs shaping a world without HIV/AIDS.

11/30/2025

Breakthrough medicines don’t happen overnight—they are the result of billions in investment and the hard work of the over one million men and women across America’s biopharmaceutical industry who show up every day to push science forward.

With more than 5,000 clinical trial sites reaching 900,000 patients nationwide, the U.S. leads the world in biomedical research and development. These trials bring tomorrow’s treatments to Americans first, often years before they’re available elsewhere.

The impact expands beyond scientific progress. With a new $500 billion investment in U.S. manufacturing and infrastructure, biopharmaceutical companies are strengthening local economies and supporting good jobs in communities across the country.

Learn more:
https://innovation.org/american-investment/

Address

670 Maine Avenue SW Ste. 1000
Washington D.C., DC
20024

Telephone

+12028353400

Website

Alerts

Be the first to know and let us send you an email when PhRMA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to PhRMA:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category